Implications of the asthma guidelines for the clinician

Journal of Allergy and Clinical Immunology

Volumn 120, Issue 5, 2007, Pages 1021-1022

  Stoloff, Stuart W ^a  

^a UNIVERSITY OF NEVADA SCHOOL OF MEDICINE   (United States)

Author keywords

asthma guidelines; control; impairment; inhaled corticosteroids; long acting bronchodilators; responsiveness; risk; Severity

Indexed keywords

BRONCHODILATING AGENT; CORTICOSTEROID; LEUKOTRIENE RECEPTOR BLOCKING AGENT; MORPHINE; SALBUTAMOL; THEOPHYLLINE;

ADJUVANT THERAPY; ADULT; AROUSAL; ASTHMA; CASE REPORT; COMBINATION CHEMOTHERAPY; CORTICOSTEROID THERAPY; COUGHING; DISEASE CONTROL; DISEASE EXACERBATION; DISEASE SEVERITY; DRUG DOSE INCREASE; EDITORIAL; FORCED EXPIRATORY VOLUME; HUMAN; LOW DRUG DOSE; LUNG FUNCTION TEST; MALE; MONOTHERAPY; PERFORMANCE; PRACTICE GUIDELINE; PRIORITY JOURNAL; RECOMMENDED DRUG DOSE; SPIROMETRY; TREATMENT RESPONSE; URINE RETENTION;

ADULT; ASTHMA; HUMANS; MALE; PRACTICE GUIDELINES AS TOPIC; SEVERITY OF ILLNESS INDEX; UNITED STATES;

EID: 35649012796     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2007.02.027     Document Type: Editorial

References (2)

1. National Heart, Lung, and Blood Institute, National Asthma Education and Prevention Program. Full report of the expert panel: guidelines for the diagnosis and management of asthma (EPR-3). Available at: http://www.nhlbi.nih.gov/gudielines/asthma/epr3/. Accessed February 16, 2007.
2. Stoloff S.W., and Boushey H.A. Severity, control, and responsiveness in asthma. J Allergy Clin Immunol 117 (2006) 544-548